Iqbal S. Grewal

13.0k total citations · 1 hit paper
125 papers, 10.8k citations indexed

About

Iqbal S. Grewal is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Iqbal S. Grewal has authored 125 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Immunology, 41 papers in Radiology, Nuclear Medicine and Imaging and 31 papers in Molecular Biology. Recurrent topics in Iqbal S. Grewal's work include T-cell and B-cell Immunology (46 papers), Monoclonal and Polyclonal Antibodies Research (41 papers) and Immunotherapy and Immune Responses (36 papers). Iqbal S. Grewal is often cited by papers focused on T-cell and B-cell Immunology (46 papers), Monoclonal and Polyclonal Antibodies Research (41 papers) and Immunotherapy and Immune Responses (36 papers). Iqbal S. Grewal collaborates with scholars based in United States, Netherlands and France. Iqbal S. Grewal's co-authors include Richard A. Flavell, R. A. Flavell, Jianchao Xu, Vishva M. Dixit, Minhong Yan, Hua Wang, Dhaya Seshasayee, Daniel B. Tumas, Che‐Leung Law and Ezogelin Oflazoglu and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Iqbal S. Grewal

122 papers receiving 10.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1998 1.3k citations Iqbal S. Grewal et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iqbal S. Grewal United States	56	7.7k	2.3k	2.0k	1.3k	873	125	10.8k
William C. Fanslow United States	58	9.6k 1.3×	2.3k 1.0×	2.3k 1.1×	1.0k 0.8×	699 0.8×	108	13.1k
Richard A. Kroczek Germany	54	9.2k 1.2×	2.2k 0.9×	2.1k 1.0×	682 0.5×	909 1.0×	103	12.5k
Ian C. M. MacLennan United Kingdom	54	8.8k 1.1×	1.4k 0.6×	2.2k 1.1×	1.4k 1.1×	464 0.5×	99	12.0k
Daisuke Kitamura Japan	47	6.4k 0.8×	1.3k 0.6×	3.2k 1.6×	979 0.8×	827 0.9×	148	9.8k
Richard J. Armitage United States	45	7.1k 0.9×	1.8k 0.8×	1.6k 0.8×	712 0.6×	484 0.6×	75	9.3k
Robert Brink Australia	58	10.6k 1.4×	1.8k 0.8×	3.3k 1.6×	1.7k 1.3×	906 1.0×	128	14.0k
Andrew G. Farr United States	56	8.5k 1.1×	2.0k 0.9×	2.6k 1.3×	788 0.6×	813 0.9×	124	13.2k
Carola G. Vinuesa Australia	54	11.2k 1.5×	1.7k 0.7×	2.9k 1.4×	833 0.7×	983 1.1×	117	14.8k
Marie Kosco‐Vilbois Switzerland	50	5.8k 0.8×	1.4k 0.6×	2.1k 1.1×	1.0k 0.8×	444 0.5×	142	8.9k
Hans Acha‐Orbea Switzerland	55	9.5k 1.2×	1.6k 0.7×	2.0k 1.0×	1.3k 1.0×	2.2k 2.5×	172	13.2k

Countries citing papers authored by Iqbal S. Grewal

Since Specialization

Citations

This map shows the geographic impact of Iqbal S. Grewal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iqbal S. Grewal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iqbal S. Grewal more than expected).

Fields of papers citing papers by Iqbal S. Grewal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iqbal S. Grewal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iqbal S. Grewal. The network helps show where Iqbal S. Grewal may publish in the future.

Co-authorship network of co-authors of Iqbal S. Grewal

This figure shows the co-authorship network connecting the top 25 collaborators of Iqbal S. Grewal. A scholar is included among the top collaborators of Iqbal S. Grewal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iqbal S. Grewal. Iqbal S. Grewal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grewal, Iqbal S., et al.. (2023). A Case Report on The Recognition of Granulomatous Mastitis and its Treatment. 3(1). 1–3. 1 indexed citations

Borrok, M. Jack, Yonghai Li, Jun Chen, et al.. (2022). Conduit CAR: Redirecting CAR T-Cell Specificity with A Universal and Adaptable Bispecific Antibody Platform. Cancer Research Communications. 2(3). 146–157. 9 indexed citations

Ganesan, Rajkumar, Vijaykumar Chennupati, Balaji Ramachandran, et al.. (2021). Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia. Leukemia. 35(8). 2274–2284. 49 indexed citations

Dees, Sundee, et al.. (2021). Overcoming the challenges associated with CD3+ T-cell redirection in cancer. British Journal of Cancer. 124(6). 1037–1048. 75 indexed citations

Dees, Sundee, Rajkumar Ganesan, Sanjaya Singh, & Iqbal S. Grewal. (2020). Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 19(12). 2409–2421. 78 indexed citations

Cortés‐Selva, Diana, B. Dasgupta, Sanjaya Singh, & Iqbal S. Grewal. (2020). Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy. Trends in Pharmacological Sciences. 42(1). 45–59. 38 indexed citations

Dees, Sundee, Rajkumar Ganesan, Sanjaya Singh, & Iqbal S. Grewal. (2020). Bispecific Antibodies for Triple Negative Breast Cancer. Trends in cancer. 7(2). 162–173. 44 indexed citations

Gordon, Renata E., Jennifer F. Nemeth, Sanjaya Singh, Russell B. Lingham, & Iqbal S. Grewal. (2020). Harnessing SLE Autoantibodies for Intracellular Delivery of Biologic Therapeutics. Trends in biotechnology. 39(3). 298–310. 18 indexed citations

Dees, Sundee, Rajkumar Ganesan, Sanjaya Singh, & Iqbal S. Grewal. (2020). Regulatory T cell targeting in cancer: Emerging strategies in immunotherapy. European Journal of Immunology. 51(2). 280–291. 82 indexed citations

10.

Wiehagen, Karla R., Natasha Girgis, Douglas H. Yamada, et al.. (2017). Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity. Cancer Immunology Research. 5(12). 1109–1121. 135 indexed citations

11.

Lewis, Timothy S., Kim K. Emmerton, Jeffrey Lau, et al.. (2011). Distinct Apoptotic Signaling Characteristics of the Anti-CD40 Monoclonal Antibody Dacetuzumab and Rituximab Produce Enhanced Antitumor Activity in Non-Hodgkin Lymphoma. Clinical Cancer Research. 17(14). 4672–4681. 27 indexed citations

12.

Sutherland, May Kung, Changpu Yu, Martha E. Anderson, et al.. (2010). 5-Azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia. mAbs. 2(4). 440–448. 24 indexed citations

13.

Oflazoglu, Ezogelin, Tamar E. Boursalian, Weiping Zeng, et al.. (2009). Blocking of CD27-CD70 Pathway by Anti-CD70 Antibody Ameliorates Joint Disease in Murine Collagen-Induced Arthritis. The Journal of Immunology. 183(6). 3770–3777. 47 indexed citations

14.

McEarchern, Julie A., Leia M. Smith, Charlotte F. McDonagh, et al.. (2008). Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70. Clinical Cancer Research. 14(23). 7763–7772. 70 indexed citations

15.

Oflazoglu, Ezogelin, Ivan J. Stone, Kristine A. Gordon, et al.. (2008). Potent Anticarcinoma Activity of the Humanized Anti-CD70 Antibody h1F6 Conjugated to the Tubulin Inhibitor Auristatin via an Uncleavable Linker. Clinical Cancer Research. 14(19). 6171–6180. 93 indexed citations

16.

Lewis, Timothy S., Jamie B. Miyamoto, May Kung Sutherland, et al.. (2007). The humanized anti-CD40 monoclonal antibody, SGN-40, signals apoptosis in non-Hodgkin's lymphoma by dual mechanisms. Molecular Cancer Therapeutics. 6. 1 indexed citations

17.

Gerber, Hans‐Peter, Ivan J. Stone, Mechthild Jonas, et al.. (2007). Humanized anti-CD19 auristatin antibody-drug conjugates display potent antitumor activity in preclinical models of B-cell malignancies. Molecular Cancer Therapeutics. 6. 2 indexed citations

18.

Tai, Yu‐Tzu, Xianfeng Li, Laurence Catley, et al.. (2005). Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40–Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications. Cancer Research. 65(24). 11712–11720. 132 indexed citations

19.

Ghoneum, Mamdooh, et al.. (2003). Phagocytosis of candida albicans by lymphatic tumour cells in vitro. Acta Histochemica. 105(2). 127–133. 14 indexed citations

20.

Soon‐Shiong, Patrick, et al.. (1990). An in vitro method of assessing the immunoprotective properties of microcapsule membranes using pancreatic and tumor cell targets.. PubMed. 22(2). 754–5. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact